Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionFocus on new products at pharma companies as generic Revlimid opportunity draws to a close

    Focus on new products at pharma companies as generic Revlimid opportunity draws to a close

    The current market restrictions that are powering generic Revlimid revenues will end in January 2026

    R. Sree Ram
    January 09, 2025 / 08:18 IST
    Companies have several high value drugs in the pipeline
    • PRO Panorama

      Moneycontrol Pro Panorama | Fresh blood in banking

      Oct 24, 2025 / 03:17 PM IST

      For Moneycontrol's Pro Panorama October 24 edition: Indian elections are caught in a populist loop, walking the fine line between ...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts